HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pancreatic stone protein is highly increased during posttraumatic sepsis and activates neutrophil granulocytes.

AbstractOBJECTIVES:
The level of pancreatic stone protein/regenerating protein (PSP/reg), a secretory protein produced in the pancreas, increases dramatically during pancreatic disease. However, after stress (e.g., anesthesia), PSP/reg levels are increased transiently in animals without pancreatic injury. Therefore, we aimed to determine whether PSP/reg is an acute-phase protein after nonpancreatic trauma.
PATIENTS:
Eighty-three polytraumatic patients without pancreatic damage.
MEASUREMENTS AND MAIN RESULTS:
We compared serum PSP/reg levels from polytraumatic patients without pancreatic damage with those in healthy controls (n = 38). C-reactive protein, interleukin-6, procalcitonin, and leukocyte numbers were also compared. The expression of CD62L and CD11b on neutrophils after exposure to PSP/reg was analyzed by flow cytometry. Thirty-three patients (39%) developed sepsis, 32 (38%) had local infections, and 18 (21%) had no infections. At admission, PSP/reg serum levels (10.2 [6.2-14.5] ng/mL; median [interquartile range]) were comparable with those in healthy controls (10.4 [7.5-12.3] ng/mL). During hospital stay, PSP/reg levels were elevated significantly in patients with sepsis (146.4 ng/mL) and in patients with infections (111.4 ng/mL) compared with patients without infections (22.8 ng/mL). Furthermore, binding of fluorescein isothiocyanate-labeled recombinant PSP/reg to human neutrophils was demonstrated. Recombinant PSP/reg elicited a dose-dependent shedding of L-selectin (CD62L) and upregulation of beta2-integrin (CD11b) in neutrophils, which indicates that PSP/reg activates neutrophils.
CONCLUSIONS:
We conclude that PSP/reg is up-regulated in blood after trauma, and the PSP/reg level is related to the severity of inflammation. Furthermore, PSP/reg binds to and activates neutrophils. Therefore, PSP/reg might be an acute-phase protein that could serve as a marker for posttraumatic complications.
AuthorsMarius Keel, Luc Härter, Theresia Reding, Li-Kang Sun, Martin Hersberger, Burkhardt Seifert, Daniel Bimmler, Rolf Graf
JournalCritical care medicine (Crit Care Med) Vol. 37 Issue 5 Pg. 1642-8 (May 2009) ISSN: 1530-0293 [Electronic] United States
PMID19325491 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Acute-Phase Proteins
  • Biomarkers
  • Lithostathine
  • L-Selectin
  • C-Reactive Protein
Topics
  • Acute-Phase Proteins (metabolism)
  • Biomarkers (metabolism)
  • C-Reactive Protein (metabolism)
  • Case-Control Studies
  • Chi-Square Distribution
  • Critical Care (methods)
  • Critical Illness (mortality, therapy)
  • Female
  • Hospital Mortality (trends)
  • Humans
  • Injury Severity Score
  • Intensive Care Units
  • L-Selectin (metabolism)
  • Lithostathine (blood, metabolism)
  • Male
  • Middle Aged
  • Multiple Trauma (complications, diagnosis)
  • Neutrophil Infiltration (physiology)
  • Pancreas (metabolism, physiopathology)
  • Probability
  • Prognosis
  • Sensitivity and Specificity
  • Sepsis (blood, etiology, mortality)
  • Severity of Illness Index
  • Statistics, Nonparametric
  • Survival Analysis
  • Up-Regulation
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: